Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Weitzman Aaron — Tango Therapeutics, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / Weitzman Aaron

Weitzman Aaron

Chief Medical Officer at Tango Therapeutics, Inc. · on record since Dec 5, 2022

Insider trading activity of Weitzman Aaron

Transactions on record: 1; since Dec 5, 2022

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Dec 5, 2022

Figures computed from official regulatory filings — methodology.

Companies where Weitzman Aaron has traded

Tango Therapeutics, Inc.1 tx · Dec 5, 2022

Track record of Weitzman Aaron

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Weitzman Aaron

Co-insiders of Weitzman Aaron

Avery James BTango Therapeutics, Inc.
Azelby RobertTango Therapeutics, Inc.
Barry DouglasTango Therapeutics, Inc.
BAUM CHARLES MTango Therapeutics, Inc.
BCTG Holdings, LLCTango Therapeutics, Inc.
Beauchamp MichaelTango Therapeutics, Inc.
Beckman DaniellaTango Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Borisy AlexisTango Therapeutics, Inc.

Boxer Asset Management Inc.Tango Therapeutics, Inc.

Boxer Capital, LLCTango Therapeutics, Inc.

Boxer Capital Management, LLCTango Therapeutics, Inc.

Braslyn Ltd.Tango Therapeutics, Inc.

Calhoun Lesley AnnTango Therapeutics, Inc.

Christensen JamieTango Therapeutics, Inc.

Crystal AdamTango Therapeutics, Inc.

Davis Aaron I.Tango Therapeutics, Inc.

EcoR1 Capital, LLCTango Therapeutics, Inc.

Ellis Andrew RuelTango Therapeutics, Inc.

Fuglesang ChristopherTango Therapeutics, Inc.

Gall MatthewTango Therapeutics, Inc.

Heyman Richard A.Tango Therapeutics, Inc.

Huang AlanTango Therapeutics, Inc.

Huber Reid MTango Therapeutics, Inc.

Ketchum John BTango Therapeutics, Inc.

Lee SungTango Therapeutics, Inc.

LEWIS JOSEPHTango Therapeutics, Inc.

MVA Investors, LLCTango Therapeutics, Inc.

Newcomb JessicaTango Therapeutics, Inc.

Nuechterlein CaroleTango Therapeutics, Inc.

Peters MalteTango Therapeutics, Inc.

Pothula KanishkaTango Therapeutics, Inc.

Rothenberg MaceTango Therapeutics, Inc.

Rudoltz MarcTango Therapeutics, Inc.

Third Rock Ventures GP IV, L.P.Tango Therapeutics, Inc.

Third Rock Ventures GP VI, L.P.Tango Therapeutics, Inc.

Third Rock Ventures IV, L.P.Tango Therapeutics, Inc.

Third Rock Ventures VI, L.P.Tango Therapeutics, Inc.

TRV GP IV, LLCTango Therapeutics, Inc.

TRV GP VI, LLCTango Therapeutics, Inc.

Weber BarbaraTango Therapeutics, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Tango Therapeutics, Inc.	Dec 5, 2022	AwardD	350,000	0.00 USD	$0	SEC